| Financial Year |
March 31 2023 |
| Monetary Funds |
3,006,933,493.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
84,985,316.28 |
| Accounts Receivable |
224,209,948.18 |
| Advances to Suppliers |
125,691,275.33 |
| Other Receivables |
38,937,460.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,624,069,567.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
378,240,027.99 |
| Total Current Assets |
11,479,125,230.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
66,503,095.16 |
| Investment Properties |
-- |
| Fixed Assetes |
22,244,637,533.23 |
| Under-construction Projects |
3,775,012,684.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,210,506,768.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,330,400.00 |
| Deferred Income Tax Assets |
375,383,024.23 |
| Other Non-Current Assets |
171,728,879.00 |
| Sub-Total of Non-Current Assets |
30,545,129,405.78 |
| Total Assets |
42,024,254,636.00 |
| Short-Term Loans |
7,189,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,900,850,000.00 |
| Accounts Payable |
7,443,272,369.18 |
| Accounts Received In Advance |
3,110,307.37 |
| Employee Compensation Payable |
25,078,308.45 |
| Taxes Payable |
70,982,255.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
189,963,260.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,373,306,404.72 |
| Other Current Liabilities |
85,667,346.43 |
| Sub-Total of Current Liabilities |
21,940,209,839.26 |
| Long-term Loans |
8,463,190,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,945,495.90 |
| Deferred Income Tax Liabilities |
18,739,626.10 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
8,840,727,767.16 |
| Total Liabilities |
30,780,937,606.42 |
| Paid-In Capital(Or Share Stock) |
6,263,357,424.00 |
| Capital Surplus |
6,709,809,645.05 |
| Surplus Reserve |
1,476,533,376.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-3,232,835,943.10 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,243,317,029.58 |
| Owner's Equity（Stockholder's Equity） |
11,243,317,029.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
42,024,254,636.00 |
